RIGL Financials
Rigel Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$47.50
Market Cap
$338.32M
P/E Ratio
6.5
EPS
$6.19
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$179.28M
Gross Profit
-
Operating Income
-
Net Income
$17.48M
EPS (Diluted)
$0.99
Balance Sheet Highlights
Total Assets
$163.98M
Total Liabilities
$160.69M
Shareholders Equity
-
Cash & Equivalents
$56.75M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$31.47M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
40.9%
Net Margin
40.2%
ROE
220.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is RIGL revenue?
RIGL's most recent quarterly revenue was $179.28M. Annual revenue can be calculated by summing the four most recent quarters.
Is RIGL profitable?
RIGL reported a profit of $17.48M in the most recent quarter. The net profit margin is 40.2%.
What is RIGL market cap?
RIGL has a market capitalization of $338.32M, making it a small-cap stock.
Does RIGL have debt?
View RIGL's balance sheet for debt information.
What is RIGL cash flow?
Cash flow data is available in the full financial statements.